About
Sarcio develops proprietary biologics based on induced pluripotent stem cells to produce exosomes that promote cartilage regeneration and repair for osteoarthritis treatment in both human and animal health.
Explore Sarcio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.